Androgen Deprivation Therapy (ADT) and High Dose Definitive Radiotherapy (RT) ± Whole Pelvic RT in Patients with Unfavorable Intermediate or Favorable High-Risk Prostate Cancer: Early Results of a Phase III Randomized Controlled Trial
Mack Roach, Theodore Karrison, H.T. Chung, A.J. Chang, Leonard G. Gomella, I.C.J. Hsu, G. Morton, Robert E. Wallace, B. Movsas, D.W. Bruner, A.P. Dicker, Deborah E. Citrin, I. Kauffman, J.M. Michalski, E. Vigneault, Michael A. Papagikos, D.E. Spratt, A. Jani, Timothy D. Johnson, H.M. Sandler
Topics & Concepts
MedicineProstate cancerAndrogen deprivation therapyRadiation therapyRandomized controlled trialClinical endpointCumulative incidenceInterim analysisUrologyExternal beam radiotherapyProstateLymph nodeBrachytherapyInternal medicineOncologyIncidence (geometry)SurgeryCohortHazard ratioData monitoring committeeHormonal therapyClinical trialStage (stratigraphy)Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchAdvanced Radiotherapy Techniques